✦ LIBER ✦

Vascular targeting therapies for treatment of malignant disease

✍ Scribed by Stephen L. Brown; Andrew Kolozsvary; Jae Ho Kim

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 65 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21120

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular-targeting therapies for treatme

Vascular-targeting therapies for treatment of malignant disease

✍ Dietmar W. Siemann; David J. Chaplin; Michael R. Horsman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

## Abstract ## BACKGROUND Tumor endothelium represents a valuable target for cancer therapy. The vasculature plays a critical role in the survival and continued growth of solid tumor masses; in addition, the inherent differences between tumor blood vessels and blood vessels associated with normal

Combined vascular targeted imaging and t

Combined vascular targeted imaging and therapy: A paradigm for personalized treatment

✍ King C.P. Li; Samira Guccione; Mark D. Bednarski 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

In order to be successful in personalizing treatment, methods for selecting patients as well as good surrogate biomarkers for monitoring the effects of treatment are required in addition to development of an efficacious targeted therapy. We have developed a polymerized nanoparticle platform technolo

Molecularly targeted therapy for maligna

Molecularly targeted therapy for malignant glioma

✍ Sith Sathornsumetee; David A. Reardon; Annick Desjardins; Jennifer A. Quinn; Jam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 1 views

## Abstract Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained dismal. Understanding the molecular pathogenesis of glioma may lead to a rational development of new therapies.

Molecular targets for retinal vascular d

Molecular targets for retinal vascular diseases

✍ Peter A. Campochiaro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract The elucidation of the molecular pathogenesis of a disease in animal models provides candidate targets for treatment. As specific antagonists for a target are developed and tested in clinical trials, if benefit is achieved, the candidate becomes a validated target. Validated targets sti

Ligand-Based Vascular Targeting of Disea

Ligand-Based Vascular Targeting of Disease

✍ Jascha-N. Rybak; Eveline Trachsel; Joerg Scheuermann; Dario Neri 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB

Photodynamic therapy for treatment of ma

Photodynamic therapy for treatment of malignant cutaneous lesions

✍ Dr. Stephen M. Waldow; Rocco V. Lobraico; Irmgard K. Kohler; Silas Wallk; Helen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Photodynamic therapy, employing either hematoporphyrin derivative or dihematoporphyrin ether as the photosensitizer and an argon-pumped tunable dye laser as the activating light source, was used to treat ten patients who had primary or recurrent basal or squamous cell carcinoma or infiltrating ducta